Banque Cantonale Vaudoise - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 373 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.

Quarter-by-quarter ownership
Banque Cantonale Vaudoise ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$35,000
+6.1%
467
+9.1%
0.00%
+100.0%
Q1 2022$33,000
-71.3%
428
-66.4%
0.00%
-75.0%
Q4 2021$115,000
-20.7%
1,273
-18.9%
0.00%
-33.3%
Q3 2021$145,000
-51.3%
1,569
-59.0%
0.01%
-53.8%
Q2 2021$298,000
-23.4%
3,831
-26.5%
0.01%
-35.0%
Q1 2021$389,000
-54.3%
5,212
+4.2%
0.02%
-57.4%
Q4 2020$852,000
-14.0%
5,004
-29.1%
0.05%
-26.6%
Q3 2020$991,000
+11.7%
7,062
+27.7%
0.06%
-1.5%
Q2 2020$887,000
+210.1%
5,529
+89.1%
0.06%
+170.8%
Q1 2020$286,000
-29.6%
2,924
-7.1%
0.02%
-14.3%
Q4 2019$406,0003,1490.03%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Ikarian Capital, LLC 399,400$35,962,0005.36%
Avoro Capital Advisors LLC 3,125,000$281,406,0004.79%
Varenne Capital Partners 324,661$29,236,0004.34%
Evolutionary Tree Capital Management, LLC 96,695$8,707,0004.18%
Ally Bridge Group (NY) LLC 120,000$10,806,0003.78%
Casdin Capital, LLC 1,350,000$121,568,0003.43%
Ghost Tree Capital, LLC 100,000$9,005,0003.23%
GREAT POINT PARTNERS LLC 145,405$13,094,0002.91%
Camber Capital Management LP 825,000$74,291,0002.55%
Alpha DNA Investment Management LLC 17,522$1,577,0001.00%
View complete list of SAREPTA THERAPEUTICS INC shareholders